These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12619892)
1. Involvement of beta 1,4 galactosyltransferase 1 and Gal beta1-->4GlcNAc groups in human hepatocarcinoma cell apoptosis. Zhang S; Cai M; Zhang SW; Hu Y; Gu JX Mol Cell Biochem; 2003 Jan; 243(1-2):81-6. PubMed ID: 12619892 [TBL] [Abstract][Full Text] [Related]
2. Constitutively active PKB/Akt inhibited apoptosis and down-regulated beta1,4-galactosyltransferase 1 in hepatocarcinoma cells. Zhu X; Chen S; Yin X; Shen A; Ji S; Shen Z; Gu J Biochem Biophys Res Commun; 2003 Sep; 309(2):279-85. PubMed ID: 12951046 [TBL] [Abstract][Full Text] [Related]
3. Two specific inhibitors of the phosphatidylinositol 3-kinase LY294002 and wortmannin up-regulate beta1,4-galactosyltransferase I and thus sensitize SMMC-7721 human hepatocarcinoma cells to cycloheximide-induced apoptosis. Shen J; Jiang J; Wei Y; Zhou L; Liu D; Zhou J; Gu J Mol Cell Biochem; 2007 Oct; 304(1-2):361-7. PubMed ID: 17557191 [TBL] [Abstract][Full Text] [Related]
4. Effect of p58GTA on beta-1,4-galactosyltransferase 1 activity and cell-cycle in human hepatocarcinoma cells. Zhang SW; Xu SL; Cai MM; Yan J; Zhu XY; Hu Y; Gu JX Mol Cell Biochem; 2001 May; 221(1-2):161-8. PubMed ID: 11506180 [TBL] [Abstract][Full Text] [Related]
5. Direct interaction between surface β1,4-galactosyltransferase 1 and epidermal growth factor receptor (EGFR) inhibits EGFR activation in hepatocellular carcinoma. Tang W; Weng S; Zhang S; Wu W; Dong L; Shen X; Zhang S; Gu J; Xue R Biochem Biophys Res Commun; 2013 May; 434(3):449-54. PubMed ID: 23583406 [TBL] [Abstract][Full Text] [Related]
6. Cell surface beta 1, 4-galactosyltransferase 1 promotes apoptosis by inhibiting epidermal growth factor receptor pathway. Li Z; Zong H; Kong X; Zhang S; Wang H; Sun Q; Gu J Mol Cell Biochem; 2006 Oct; 291(1-2):69-76. PubMed ID: 16786197 [TBL] [Abstract][Full Text] [Related]
7. Effect of suppression of TGF-beta1 expression on cell-cycle and gene expression of beta-1,4-galactosyltransferase 1 in human hepatocarcinoma cells. Zhang SW; Lin WS; Ying XL; Zhu D; Guo MY; Gu JX Biochem Biophys Res Commun; 2000 Jul; 273(3):833-8. PubMed ID: 10891333 [TBL] [Abstract][Full Text] [Related]
8. Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. Saitoh A; Aoyagi Y; Asakura H Arch Biochem Biophys; 1993 Jun; 303(2):281-7. PubMed ID: 8390218 [TBL] [Abstract][Full Text] [Related]
9. The effect on IgG glycosylation of altering beta1, 4-galactosyltransferase-1 activity in B cells. Keusch J; Lydyard PM; Delves PJ Glycobiology; 1998 Dec; 8(12):1215-20. PubMed ID: 9858643 [TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of beta1,4-galactosyltransferase in human skin tissue. Mizukawa Y; Ikehara Y; Nishihara S; Shiohara T; Narimatsu H J Dermatol Sci; 1999 Jul; 20(3):183-90. PubMed ID: 10397389 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of poly-N-acetyllactosamine synthesis in Sf-9 cells upon transfection of individual human beta-1,4-galactosyltransferase I, II, III, IV, V and VI cDNAs. Sato T; Guo S; Furukawa K Biochimie; 2001 Aug; 83(8):719-25. PubMed ID: 11530203 [TBL] [Abstract][Full Text] [Related]
12. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. Yamashita K; Taketa K; Nishi S; Fukushima K; Ohkura T Cancer Res; 1993 Jul; 53(13):2970-5. PubMed ID: 7686446 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel UDP-Gal:GalNAc beta 1-4GlcNAc-R beta 1-3-galactosyltransferase in the connective tissue of the snail Lymnaea stagnalis. Mulder H; Schachter H; De Jong-Brink M; Van der Ven JG; Kamerling JP; Vliegenthart JF Eur J Biochem; 1991 Oct; 201(2):459-65. PubMed ID: 1935942 [TBL] [Abstract][Full Text] [Related]
14. Quantitative differences in GlcNAc:beta1-->3 and GlcNAc:beta1-->4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa. Seko A; Ohkura T; Kitamura H; Yonezawa S; Sato E; Yamashita K Cancer Res; 1996 Aug; 56(15):3468-73. PubMed ID: 8758913 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated expression of antisense RNA transcripts complementary to pig alpha(1,3) galactosyltransferase mRNA inhibits expression of Gal alpha(1,3) Gal epitope. Xing L; Xia GH; Bai XF; Fei J; Guo LH Acta Pharmacol Sin; 2000 Nov; 21(11):1005-10. PubMed ID: 11501054 [TBL] [Abstract][Full Text] [Related]
16. Kinetic study of human beta-1,4-galactosyltransferase expressed in E. coli. Nakazawa K; Furukawa K; Narimatsu H; Kobata A J Biochem; 1993 Jun; 113(6):747-53. PubMed ID: 8370673 [TBL] [Abstract][Full Text] [Related]
17. Presence of polysialic acid and HNK-1 carbohydrate on brain glycoproteins from beta-1,4-galactosyltransferase-knockout mice. Kido M; Asano M; Iwakura Y; Ichinose M; Miki K; Furukawa K Biochem Biophys Res Commun; 1998 Apr; 245(3):860-4. PubMed ID: 9588205 [TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility to apoptosis of human hepatocarcinoma cells transfected with antisense N-acetylglucosaminyltransferase V cDNA. Guo HB; Liu F; Chen HL Biochem Biophys Res Commun; 1999 Oct; 264(2):509-17. PubMed ID: 10529394 [TBL] [Abstract][Full Text] [Related]
19. Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell. Qin J; Xu Y; Li X; Wu Y; Zhou J; Wang G; Chen L Exp Mol Pathol; 2014 Feb; 96(1):1-8. PubMed ID: 24211718 [TBL] [Abstract][Full Text] [Related]
20. Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection. Gorelik E; Xu F; Henion T; Anaraki F; Galili U Cancer Res; 1997 Jan; 57(2):332-6. PubMed ID: 9000578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]